DK2829881T3 - Colorectal cancer diagnostic - Google Patents

Colorectal cancer diagnostic Download PDF

Info

Publication number
DK2829881T3
DK2829881T3 DK14178981.8T DK14178981T DK2829881T3 DK 2829881 T3 DK2829881 T3 DK 2829881T3 DK 14178981 T DK14178981 T DK 14178981T DK 2829881 T3 DK2829881 T3 DK 2829881T3
Authority
DK
Denmark
Prior art keywords
igfbp2
m2pk
dkk
leu
epcam
Prior art date
Application number
DK14178981.8T
Other languages
Danish (da)
English (en)
Inventor
Leah Jane Cosgrove
Bruce Tabor
Antony Wilks Burgess
Edouard Collins Nice
Original Assignee
Vision Tech Bio Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010903140A external-priority patent/AU2010903140A0/en
Application filed by Vision Tech Bio Pty Ltd filed Critical Vision Tech Bio Pty Ltd
Application granted granted Critical
Publication of DK2829881T3 publication Critical patent/DK2829881T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK14178981.8T 2010-07-14 2011-07-14 Colorectal cancer diagnostic DK2829881T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2010903140A AU2010903140A0 (en) 2010-07-14 Diagnostic for colorectal cancer
EP11806149.8A EP2593795A4 (en) 2010-07-14 2011-07-14 DIAGNOSIS FOR DARM CANCER

Publications (1)

Publication Number Publication Date
DK2829881T3 true DK2829881T3 (en) 2017-12-04

Family

ID=45468816

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14178981.8T DK2829881T3 (en) 2010-07-14 2011-07-14 Colorectal cancer diagnostic

Country Status (13)

Country Link
US (2) US20130345322A1 (enExample)
EP (2) EP2593795A4 (enExample)
JP (1) JP6061344B2 (enExample)
CN (2) CN103140760B (enExample)
AU (1) AU2011279555B2 (enExample)
BR (1) BR112013000745B1 (enExample)
DK (1) DK2829881T3 (enExample)
ES (1) ES2653646T3 (enExample)
IN (1) IN2013CN01129A (enExample)
NO (1) NO2829881T3 (enExample)
PT (1) PT2829881T (enExample)
RU (1) RU2013103995A (enExample)
WO (1) WO2012006681A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011279555B2 (en) 2010-07-14 2016-10-20 Vision Tech Bio Pty Ltd Diagnostic for colorectal cancer
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
MX2013008833A (es) 2011-02-02 2013-12-06 Amgen Inc Metodos y composiciones relacionadas con la inhibicion de receptor del factor de crecimiento similar a la insulina 1 (igf-1r).
PT2883057T (pt) * 2012-08-09 2019-03-06 Univ Toulouse 3 Paul Sabatier Diagnóstico de insuficiência cardíaca
GB201218341D0 (en) * 2012-10-12 2012-11-28 Orign Sciences Ltd Diagnostic method
AU2015237229A1 (en) * 2014-03-28 2016-11-10 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
MX375557B (es) * 2014-07-18 2025-03-06 Sanofi Sa Método para predecir el resultado de un tratamiento con aflibercept de un paciente que se sospecha que padece un cáncer.
CN106191215B (zh) * 2015-04-29 2020-03-24 中国科学院上海生命科学研究院 肌肉萎缩相关的蛋白质分子标记Dkk-3的筛选及其应用
EP3294321B1 (en) * 2015-05-12 2024-07-31 Superlab Far East Limited Methods of determining interferon having direct inhibitory effects on tumors and uses thereof
CN105219844B (zh) * 2015-06-08 2018-12-14 华夏京都医疗投资管理有限公司 一种筛查十一种疾病的基因标志物组合、试剂盒以及疾病风险预测模型
CN105021828B (zh) * 2015-07-20 2017-07-28 上海交通大学医学院附属新华医院 通过检测三期结直肠肿瘤患者血清预测肿瘤患者预后
CN105567846A (zh) * 2016-02-14 2016-05-11 上海交通大学医学院附属仁济医院 检测粪便中细菌dna的试剂盒及其在大肠癌诊断中的应用
JP6984862B2 (ja) * 2017-03-15 2021-12-22 国立大学法人金沢大学 血中ケモカインをマーカーとして用いた大腸癌の検出
CN107164535A (zh) * 2017-07-07 2017-09-15 沈阳宁沪科技有限公司 一种无创高通量甲基化结肠癌诊断、研究和治疗方法
CN110540588B (zh) * 2018-05-28 2022-08-23 香港中文大学 一种基于肿瘤干细胞标志物EpCAM的抗原表位多肽及其应用
CN108957014A (zh) * 2018-09-27 2018-12-07 郑州大学第附属医院 结直肠癌血清标志物、表达评估方法、试剂盒及应用
EP3870030A4 (en) * 2018-10-23 2022-08-03 Blackthorn Therapeutics, Inc. SYSTEMS AND METHODS FOR SCREENING, DIAGNOSIS AND STRATIFICATION OF PATIENTS
CN109504778B (zh) * 2019-01-11 2021-11-09 复旦大学附属中山医院 一种基于表观修饰的5hmC多分子标志物及结直肠癌早期诊断模型
JP2022522803A (ja) * 2019-03-01 2022-04-20 アドバンスド マーカー ディスカバリー エセ. エレ. 結腸直腸癌及び/又はその前癌段階の診断用タンパク質シグネチャー
JP7300660B2 (ja) * 2019-04-03 2023-06-30 京都府公立大学法人 大腸がんの検出方法
JP7032764B2 (ja) * 2019-04-03 2022-03-09 京都府公立大学法人 大腸がんの検出方法
GB201906199D0 (en) * 2019-05-02 2019-06-19 Belgian Volition Sprl Method for the detection of cancer
US20220378877A1 (en) * 2019-11-13 2022-12-01 University Of Virginia Patent Foundation Treatment of clostridium difficile infections
EP3835789A1 (en) 2019-12-13 2021-06-16 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Biomarker panel for diagnosing colorectal cancer
WO2022130597A1 (ja) * 2020-12-18 2022-06-23 国立大学法人東北大学 推定装置、推定方法、推定プログラム、生成装置、及び、推定システム
CN117083525A (zh) * 2020-12-21 2023-11-17 福瑞诺姆控股公司 用于结肠细胞增殖性病症的早期检测的标志物
AU2022259871A1 (en) * 2021-04-20 2023-11-23 Vision Tech Bio Pty Ltd Biomarkers for colorectal cancer
CA3228665A1 (en) * 2021-08-11 2023-02-16 Trevor Lockett Method of detecting adenoma
WO2023128429A1 (ko) * 2021-12-31 2023-07-06 주식회사 이노제닉스 대장암 및 진행 선종의 선별 검사 방법 및 그 응용
WO2023128419A1 (ko) * 2021-12-31 2023-07-06 주식회사 이노제닉스 대장암 및 대장 용종 또는 진행 선종의 선별 방법 및 그 응용
CN114594259B (zh) * 2022-04-22 2022-09-13 北京易科拜德科技有限公司 一种新型的用于结直肠癌预后预测和诊断的模型及其应用
PL441319A1 (pl) * 2022-05-31 2023-12-04 Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu Zestaw biomarkerów białkowych i sposób diagnostyki raka jelita grubego in vitro
CN116219007A (zh) * 2022-09-15 2023-06-06 绍兴积准生物科技有限公司 检测结直肠癌的生物标志物组及其应用
CN119688988A (zh) * 2024-11-25 2025-03-25 中国医学科学院肿瘤医院 Timp1和foxp3作为诊断结直肠癌的生物标志物组合及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
JP2004198419A (ja) * 2002-12-13 2004-07-15 Bayer Healthcare Llc Timp1を用いた検出方法
US20050014165A1 (en) * 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer
EP2280285A1 (en) * 2003-09-15 2011-02-02 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
BRPI0401830A (pt) 2004-05-25 2006-01-17 Bentonit Uniao Nordeste Sa Processo de produção de pós granulados secos
US20080112888A1 (en) * 2006-06-30 2008-05-15 Schering Corporation Igfbp2 biomarker
US9060961B2 (en) 2006-11-09 2015-06-23 University Of Washington Molecules and methods for treatment and detection of cancer
US9353415B2 (en) * 2006-12-19 2016-05-31 Thomson Reuters (Scientific) Llc Methods for functional analysis of high-throughput experimental data and gene groups identified therefrom
JP2010517582A (ja) 2007-02-12 2010-05-27 ザ・ジョンズ・ホプキンス・ユニバーシティー 結腸癌の早期検出および予後診断の方法
HUE028487T2 (en) * 2007-02-27 2016-12-28 Sentoclone Int Ab Detection of tumor cell multiplex using panel of agents associated with extracellular markers
WO2008116178A2 (en) * 2007-03-21 2008-09-25 Vanderbilt University Systems and methods for diagnosis and prognosis of colorectal cancer
CA2684024A1 (en) * 2007-05-10 2008-11-20 F. Hoffmann-La Roche Ag Use of timp-1 as a marker for colorectal cancer
WO2008144345A2 (en) * 2007-05-17 2008-11-27 Bristol-Myers Squibb Company Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators
WO2009037572A2 (en) * 2007-06-04 2009-03-26 Diagnoplex Biomarker combinations for colorectal cancer
US20090017463A1 (en) * 2007-07-10 2009-01-15 Vanderbilt University Methods for predicting prostate cancer recurrence
WO2009126543A1 (en) * 2008-04-08 2009-10-15 Nuclea Biomarkers, Llc Biomarker panel for prediction of recurrent colorectal cancer
US20100111969A1 (en) * 2008-10-31 2010-05-06 Apogenix Gmbh Il-4 receptor and il-13 as prognostic markers for colon and pancreas tumors
CN102300578A (zh) * 2008-12-01 2011-12-28 延寿有限责任公司 用于改变健康、安康和寿命的方法和组合物
WO2010065940A1 (en) * 2008-12-04 2010-06-10 The Regents Of The University Of California Materials and methods for determining diagnosis and prognosis of prostate cancer
CN102326080B (zh) * 2009-02-20 2015-08-05 加利福尼亚大学董事会 A+生物标志物的试验
US20110177525A1 (en) * 2010-01-19 2011-07-21 Predictive Biosciences, Inc. Antibodies and methods of diagnosing diseases
AU2011279555B2 (en) * 2010-07-14 2016-10-20 Vision Tech Bio Pty Ltd Diagnostic for colorectal cancer

Also Published As

Publication number Publication date
US10877039B2 (en) 2020-12-29
AU2011279555B2 (en) 2016-10-20
WO2012006681A1 (en) 2012-01-19
EP2829881B1 (en) 2017-08-23
CN103140760A (zh) 2013-06-05
CN105755112A (zh) 2016-07-13
JP6061344B2 (ja) 2017-01-18
US20170205414A1 (en) 2017-07-20
US20130345322A1 (en) 2013-12-26
PT2829881T (pt) 2017-11-29
BR112013000745A2 (pt) 2016-05-24
ES2653646T3 (es) 2018-02-08
EP2593795A1 (en) 2013-05-22
EP2593795A4 (en) 2014-01-22
CN105755112B (zh) 2019-06-07
RU2013103995A (ru) 2014-08-20
EP2829881A2 (en) 2015-01-28
AU2011279555A1 (en) 2013-01-31
NO2829881T3 (enExample) 2018-01-20
IN2013CN01129A (enExample) 2015-07-31
CN103140760B (zh) 2016-01-27
EP2829881A3 (en) 2015-05-13
JP2013533977A (ja) 2013-08-29
BR112013000745B1 (pt) 2021-02-02

Similar Documents

Publication Publication Date Title
DK2829881T3 (en) Colorectal cancer diagnostic
US9964542B2 (en) Bladder cancer detection composition, kit, and associated methods
WO2008067065A2 (en) Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
US20230142920A1 (en) Kits and methods for detecting markers
CN115087869A (zh) 肺癌诊断用多种生物标志物及其用途
CN113981098A (zh) 用于肝癌诊断以及肝癌预后预测的生物标志物
CN113981097A (zh) 基于hspa4的生物标志物组及其在肝癌中的应用
CN105283763A (zh) 用于前列腺癌的生物标志物检测中的方法和阵列
US20240393336A1 (en) Biomarkers for colorectal cancer
US20150218655A1 (en) Biomarkers for prostate cancer prognosis
CN114107504A (zh) 用于检测肺癌及肺癌预后的生物标志物
CN113943815A (zh) 基于alk的生物标志物组及其应用
CN112921094A (zh) 生物标志物用于评估早期结直肠癌
CN112795658A (zh) 早期结直肠癌的基于生物标志物的诊断
US20240118282A1 (en) Kits and methods for detecting markers and determining the presence or risk of cancer
CN114015778A (zh) 预测肺癌的生物标志物组
KR20240041943A (ko) 전립선암에 대한 위험 예측 모델
CN113025717A (zh) 早期结直肠癌的指示物
CN112921095A (zh) 用于诊断早期结直肠癌的生物标志物及其应用
CN112921096A (zh) 早期结直肠癌的预测
CN113061657A (zh) 诊断早期结直肠癌的产品及系统